NEW YORK – Illumina, Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center (NYGC) on Thursday announced a collaboration to provide clinical whole-genome sequencing (WGS) to "thousands" of consenting patients in order to identify genetic disease drivers and potential therapies.